A Patient with Genetically Confirmed Myoclonus-Dystonia Responded to Anticholinergic Treatment and Improved Spontaneously

BACKGROUND: The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission. CAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Hyeok, Lyoo, Chul Hyoung, Lee, Myung Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259499/
https://www.ncbi.nlm.nih.gov/pubmed/22259621
http://dx.doi.org/10.3988/jcn.2011.7.4.231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259499/
https://www.ncbi.nlm.nih.gov/pubmed/22259621
http://dx.doi.org/10.3988/jcn.2011.7.4.231

Ejemplares similares